Core Viewpoint - Chengdu is set to host the "Invest in Chengdu" Global Investment Conference from June 18, 2025, focusing on collaboration, innovation, and future development, with significant participation from global enterprises and investment opportunities [1][2]. Investment Growth - Chengdu has seen rapid investment growth in 2023, with 497 major industrial projects introduced from January to May, marking a 182% year-on-year increase. Foreign investment reached $6.56 billion from January to April, up 58.89%, ranking first among central and western cities [1]. Global Collaboration - The conference will establish a global industrial cooperation platform, focusing on emerging industries such as commercial aerospace, artificial intelligence, and biomedicine, aiming to sign significant projects that fill industry gaps and capture new market opportunities [2][3]. Fund Initiatives - Chengdu plans to launch a chain master fund action plan with a total scale of 60 billion yuan, promoting local supply chain integration and enhancing the investment environment through innovative capital models [3]. Business Environment - Chengdu is committed to improving its business environment with 70 new policy measures aimed at attracting and retaining businesses, emphasizing a responsive and supportive approach to enterprise needs [4][6]. Economic Performance - In the first quarter of 2023, Chengdu's GDP grew by 6.0%, with private sector value added increasing by 6.2%. Fixed asset investment rose by 7.9%, with private investment up by 10.6% from January to April [6]. International Market Expansion - Chengdu is exploring new models for cross-border e-commerce and enhancing its cultural industries, such as gaming and film, to expand its international market presence [6].

Core Viewpoint - The event aims to enhance collaboration in the pharmaceutical and healthcare industry, showcasing the advantages of the Chengdu High-tech Zone and promoting the "Wutong Plan" for attracting investment and fostering industry growth [1][2] Group 1: Event Overview - The Pharmaceutical and Healthcare Industry Cooperation Conference was held in Beijing, co-hosted by the Sichuan Provincial Economic Cooperation Bureau and the Chengdu High-tech Zone Management Committee [1] - Over 70 representatives from leading companies and capital institutions, including Kexing Bio, Boston Scientific, and Merck, gathered to discuss new development paths for the industry [1] Group 2: Policy and Support - The Chengdu High-tech Zone released the "Chengdu High-tech Industrial Development Policy for the Pharmaceutical and Healthcare Industry," offering up to 30% support for major projects and up to 50% for innovative drug research and development, with a maximum of 100 million yuan per product [2] - The "Wutong Plan" is the first comprehensive service list for the biopharmaceutical industry in China, covering nine categories of professional services and 99 detailed services, facilitating the entire lifecycle from research to market [2] Group 3: Industry Ecosystem - Chengdu High-tech Zone has established a full technology chain platform for innovative drugs and medical devices, housing over 3,000 pharmaceutical and healthcare companies, including more than 800 in the medical device sector [2] - The zone has nurtured 10 listed companies in the pharmaceutical and healthcare sector and attracted over 10 Fortune 500 companies, including GE Healthcare and Medtronic [2]